Interestingly, the addition of the PNPLA3 genotype as second parameter to the models built with single cytokines improved the predictive power to discriminate HCC from the NAFLD samples. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.